Authors: Pearson, DA McGrath, NM Nozyce, M Nichols, SL Raskino, C Brouwers, P Lifschitz, MC Baker, CJ Englund, JA

Citation: Da. Pearson et al., Predicting HIV disease progression in children using measures of neuropsychological and neurological functioning, PEDIATRICS, 106(6), 2000, pp. NIL_11-NIL_20

Authors: Barroga, CF Raskino, C Fangon, MC Palumbo, PE Baker, CJ Englund, JA Spector, SA

Citation: Cf. Barroga et al., The CCR5 Delta 32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment, J INFEC DIS, 182(2), 2000, pp. 413-419

Authors: Raskino, C Pearson, DA Baker, CJ Lifschitz, MH O'Donnell, K Mintz, M Nozyce, M Brouwers, P McKinney, RE Jimenez, E Englund, JA

Citation: C. Raskino et al., Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviralregimens, PEDIATRICS, 104(3), 1999, pp. F1-F10

Authors: Palumbo, PE Raskino, C Fiscus, S Pahwa, S Schutzbank, T Spector, SA Baker, CJ Englund, JA

Citation: Pe. Palumbo et al., Virologic and immunologic response to nucleoside reverse-transcriptase inhibitor therapy among human immunodeficiency virus-infected infants and children, J INFEC DIS, 179(3), 1999, pp. 576-583